Role of Fetuin-A as a Noninvasive Biomarker in Diagnosis and Assessment of Severity of Non-Alcoholic Fatty Liver Disease.
Abdulaziz, B., abd elhamid, M., Elhoseeny, M., Mostafa, H., Elsharaby, R., Rashad, G. (2023). Role of Fetuin-A as a Noninvasive Biomarker in Diagnosis and Assessment of Severity of Non-Alcoholic Fatty Liver Disease.. EKB Journal Management System, 40(3), 784-798. doi: 10.21608/bmfj.2023.226193.1869
Badawy A. Abdulaziz; Mohamed abd elhamid; Mohamed Elhoseeny; Haitham Hosny Mostafa; Radwa Mahmoud Elsharaby; Ghadeer Mohammed Rashad. "Role of Fetuin-A as a Noninvasive Biomarker in Diagnosis and Assessment of Severity of Non-Alcoholic Fatty Liver Disease.". EKB Journal Management System, 40, 3, 2023, 784-798. doi: 10.21608/bmfj.2023.226193.1869
Abdulaziz, B., abd elhamid, M., Elhoseeny, M., Mostafa, H., Elsharaby, R., Rashad, G. (2023). 'Role of Fetuin-A as a Noninvasive Biomarker in Diagnosis and Assessment of Severity of Non-Alcoholic Fatty Liver Disease.', EKB Journal Management System, 40(3), pp. 784-798. doi: 10.21608/bmfj.2023.226193.1869
Abdulaziz, B., abd elhamid, M., Elhoseeny, M., Mostafa, H., Elsharaby, R., Rashad, G. Role of Fetuin-A as a Noninvasive Biomarker in Diagnosis and Assessment of Severity of Non-Alcoholic Fatty Liver Disease.. EKB Journal Management System, 2023; 40(3): 784-798. doi: 10.21608/bmfj.2023.226193.1869

Role of Fetuin-A as a Noninvasive Biomarker in Diagnosis and Assessment of Severity of Non-Alcoholic Fatty Liver Disease.

Benha Medical Journal
Article 17, Volume 40, Issue 3, November and December 2023, Page 784-798  XML PDF (855.89 K)
Document Type: Original Article
DOI: 10.21608/bmfj.2023.226193.1869
View on SCiNiTO View on SCiNiTO
Authors
Badawy A. Abdulaziz1; Mohamed abd elhamid2; Mohamed Elhoseeny3; Haitham Hosny Mostafa email 4; Radwa Mahmoud Elsharaby5; Ghadeer Mohammed Rashad6
1Hepatology,Gastroentrology and Infectiuos Diseses ,Benha faculty of medicine ,Benha Univerisity ,Benha ,Egypt
2Professor of Hepatology, Gastroenterology and Infectious Diseases department Faculty of Medicine, Benha University
3Department of internal medicine , Faculty of medicine, suez university
4Hepatology, Gastroenterology and Infectious diseases Faculty of medicine – Tanta University
5Department of clinical pathology, Faculty of medicine – Tanta University
6Department of Hepatology, Gastroenterology and Infectious diseases Faculty of medicine – Benha University
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is rapidly becoming one of the most common causes of chronic liver disease worldwide. The biopsy is the gold standard tool for disease diagnosis, but it is usually not accepted by the patients due to its invasive nature. The use of non-invasive biomarkers is now attaining a great interest in diagnosis and detection of the disease severity.
Aim of the work: Investigate the role of fetuin A in diagnosis and assessment of severity of non-alcoholic fatty liver disease (NAFLD). Patients and methods: This a cross sectional study included 50 patients with NAFLD and 50 healthy control subjects. All cases were submitted to history taking, clinical examination and laboratory investigation (including assessment of fetuin A), abdominal ultrasonography and fibroscan with controlled attenuated parameter (CAP scan). Results: The level of fetuin A was statistically significantly higher in the cases group as compared with the control group (1154.85±629.89 and 505.29±150.4 respectively) (p < 0.001). Fetuin-A had significant validity in prediction of NAFLD at cut off >702.5 with sensitivity 82%, specificity 90% and accuracy 86%.Conclusion: Fetuin A could be a potential marker in the diagnosis of NAFLD. Also, the marker was related to disease severity as it revealed a significant correlation with ultrasound grading and fibroscan with controlled attenuated parameter.
Keywords
NAFLD; fetuin A; CAP score; hyperlipidemia
Statistics
Article View: 96
PDF Download: 200